insulin
News/ News/ Sales and Marketing
Insulin producers face fresh lawsuit in US over pricing
Phil Taylor
Drug pricing, Eli Lilly, insulin, litigation, Novo Nordisk, Sanofi
0 Comment
Novo Nordisk once-weekly insulin clears first phase 3 test
Phil Taylor
Diabetes, drug delivery, insulin, insulin icodec, metabolic disease, Novo Nordisk
0 Comment
Market Access/ Views and analysis
Why the drug pricing debate is focused on insulin
Ben Hargreaves
Diabetes, Drug pricing, insulin, pharma, PhRMA
0 Comment
Market Access/ Views & Analysis/ Views and analysis
What is the solution to America’s deepening access to medicines crisis?
Amanda Barrell
America, insulin, Joe Biden, Pharmaceutical Research and Manufacturers of America
0 Comment
News/ News/ Sales and Marketing
Insulin price caps on the horizon as Senate leader plans vote
Phil Taylor
Diabetes, Drug pricing, insulin, legislation, US
0 Comment
News/ News/ Sales and Marketing
Civica plans shake-up of insulin sector with low-cost biosimilars
Phil Taylor
biosimilar, Civica, Eli Lilly, insulin, Novo Nordisk, pricing, Sanofi
0 Comment
Novo Nordisk launches first smart insulin pens for NHS patients
Phil Taylor
insulin, NHS, Novo Nordisk, patients, smart insulin pen, UK
0 Comment
News/ News/ Sales and Marketing
China’s insulin plans will hit 2022 revenues, says Novo Nordisk
Phil Taylor
China, insulin, Novo Nordisk, Value-based pricing
0 Comment